INVO Fertility shareholders approve increase in authorized shares from 6.25M to 250M and warrant issuance

INVO Fertility, Inc.

Authorized common shares increased from 6,250,000 to 250,000,000 via Certificate of Amendment filed Jan 22.
Shareholders approved issuance of up to 4,733,728 shares upon exercise of warrant from Dec 2025 private placement.
Stock incentive plan amended to increase available shares to 1,000,000 (approx. 10% of fully-diluted shares).
Ratification of WithumSmithBrown, PC as independent auditor for fiscal 2025 approved with 865,418 for, 39,637 against.
All proposals passed; quorum of 944,054 shares represented at special meeting.

item 5.03 item 5.07 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

INVO Fertility, Inc.: Increased authorized shares of common stock from 6,250,000 to 250,000,000 (effective 2026-01-22).

Change: charter amendment
Effective: 2026-01-22

Exact text from the filing

On January 22, 2026, the Company filed a Certificate of Amendment (the “Amendment”) to its Articles of Incorporation to increase its authorized shares of common stock from 6,250,000 shares to 250,000,000 shares.

View on SEC.gov

83 governance changes filed in the last 30 days. Browse all governance changes →

INVO Fertility, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-003628

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.